Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

J Fernando Arevalo, AAO 2021: Retinal and Choroidal Manifestations of HIV and AIDS

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 3rd 2022

We were delighted to speak with our valued Editorial Board member J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA), about his talk covering retinal and choroidal manifestations of HIV and AIDS and changes to the eye caused by pregnancy.

Questions

  1. Could you tell us a little about the retinal and choroidal manifestations of HIV and AIDS? (00:38)
  2. How does pregnancy affect the eye? (03:16)
  3. What advice would you give to primary care physicians in terms of recognizing the possible correlation between ophthalmic conditions and systemic disease? (06:25)

Speaker Disclosure: J Fernando Arevalo has received consultant and advisor fees from Abbvie, Genentech and Thea Laboratories, patents/royalty from Springer SBM LLC, and grant support from Topcon Medical Systems Inc.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of AAO 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup